Table 1.
In vivo tumor growth of D1-T286A expressing cells
| Cell line
|
Passage no.
|
No. of mice with tumors
|
Time until tumor development
|
|---|---|---|---|
| RasVa112-3T3 | N/D | 7 of 7 | 10 d |
| NIH-3T3 | p10 | 0 of 7 | N/A |
| NIH-3T3 | p20 | 0 of 7 | N/A |
| D1-3T3 | p8 | 0 of 7 | N/A |
| D1-3T3 | p22 | 0 of 7 | N/A |
| D1-T286A-3T3 | p9 | 6 of 7 | 40 d |
| D1-T286A-3T3 | p23 | 7 of 7 | 22 d |
The ability of cells from the indicated cell line and passage number (p) to form tumors in SCID mice was determined by injecting 107 cells subcutaneously into the right flank of 6-wk-old male SCID mice obtained from Charles River. The passage number for the RasV12-3T3 cells was not precisely determined (N/D) because they appear transformed at the earliest point of expression. Mice were monitored daily for tumor formation. (N/A) Mice with no apparent tumors 70 d after injection.